Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18868445 | 1.00 | ALDH1A1 (0.47) | ALDH1A1ALOX15CYP2D6TDP1TRPA1 | |
| SCHEMBL18489326 | 0.87 | ALDH1A1 (0.71) | ALDH1A1ALOX15CYP2D6TDP1TRPA1 | |
| SCHEMBL839630 | 0.87 | — | — | |
| SCHEMBL839631 | 0.87 | — | — | |
| SCHEMBL801900 | 0.87 | — | — | |
| SCHEMBL13800918 | 0.85 | ALDH1A1 (0.36) | ALDH1A1ALOX15CYP2D6TDP1TRPA1 | |
| SCHEMBL5639259 | 0.85 | — | — | |
| SCHEMBL5639261 | 0.85 | — | — | |
| SCHEMBL17207269 | 0.85 | — | — | |
| SCHEMBL2619425 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230364183-A1 | CARTILAGE-HOMING PEPTIDES | FRED HUTCHINSON CANCER CENTER | 2023-11-16 | — | — | US | disclosed |
| US-10035784-B2 | Agonists that enhanced binding of integrin-expressing cells to integrin receptors | TEXAS HEART INSTITUTE (US) | 2018-07-31 | — | — | US | disclosed |
| US-9346852-B2 | Substituted adipic acid amides and uses thereof | BRISTOL-MYERS SCUIBB COMPANY (US) | 2016-05-24 | — | — | US | disclosed |
| US-7964640-B2 | Oligomers of straight-chain and unbranched fatty acids and drugs containing these | PLT PATENT & LICENSE TRADING LTD. (GB) | 2011-06-21 | — | — | US | disclosed |
| US-20090012166-A1 | Oligomers of Straight-Chain and Unbranched Fatty Acids and Drugs Containing These | PLT PATENT & LICENSE TRADING S.L. (ES) | 2009-01-08 | — | — | US | disclosed |
| EP-1283826-B1 | A PROCESS FOR PREPARING CAROTENOID POLYENE CHAIN COMPOUNDS AND INTERMEDIATES FOR PREPARING THE SAME | KOO SANGHO (KR) | 2008-03-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230364183-A1 | CARTILAGE-HOMING PEPTIDES | CXCL12, CCL2, MATR3 | ALDH1A1 3797/4885ALOX15 4337/4885CYP2D6 4800/4885 |
| US-10035784-B2 | Agonists that enhanced binding of integrin-expressing cells to integrin receptors | ITGB7, ITGAL, ITGB1 | ALDH1A1 740/4885ALOX15 2357/4885CYP2D6 4193/4885 |
| US-20090012166-A1 | Oligomers of Straight-Chain and Unbranched Fatty Acids and Drugs Containing These | FASN, FFAR3, FFAR2 | ALDH1A1 1610/4885ALOX15 51/4885CYP2D6 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.